Current Pharmaceutical Design
Current Pharmaceutical Design is a journal indexed in SJR in Drug Discovery and Pharmacology with an H index of 190. It has an SJR impact factor of 0,611 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,611.
Current Pharmaceutical Design focuses its scope in these topics and keywords: systematic, current, arterial, reviewthe, erectile, modeling, management, pharmacological, atherosclerosis, reviewinsilico, ...
Unclaimed profile — some fields may be incomplete.
Metrics
Campos Scimago / CoP — sin series inventadas
SJR Impact
0,611
H-index
190
Docs (year)
260
Docs 3y
1077
Total refs
21803
Cites 3y
2955
Citable 3y
981
Cites/Doc 2y
2.61
Ref/Doc
83.86
Immediate OA
—
Embargoed OA
NPD
Non OA / Submission
—
Name good journals. Call out predatory ones.
Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.
Researcher reviews
Best articles by citations
Antithrombotic therapy in patients with recent stroke and atrial fibrillation
View moreVitex Diterpenoids: Structural Diversity and Pharmacological Activity
View moreCopper and Neurotoxicity in Autism Spectrum Disorder
View moreComprehensive Essential Gene Identification as a Platform for Novel Antiinfective Drug Discovery
View moreCitrus species: A Review of Traditional Uses, Phytochemistry and Pharmacology
View moreCisplatin Toxicology: The Role of Pro-inflammatory Cytokines and GABA Transporters in Cochlear Spiral Ganglion
View moreCirculating miRNAs in Successful and Unsuccessful Aging. A Mini-review
View moreCircadian-Hypoxia Link and its Potential for Treatment of Cardiovascular Disease
View moreChemotherapy of Leishmaniasis
View moreCellular and Molecular Mechanisms of Antithrombogenic Plants: A Narrative Review
View morebeta-lactam Resistance in Gram-negative Pathogens Isolated from Animals
View moreBasic Cell Biology of Trypanosoma cruzi
View moreAntithrombotic treatment after atrial fibrillation ablation
View moreA Mechanistic Approach to Anticancer Therapy: Targeting the Cell Cycle with Histone Deacetylase Inhibitors
View moreAntiatherosclerotic and Cardioprotective Effects of Time-Released Garlic Powder Pills
View moreAnti-NMDA Receptor Encephalitis, Vaccination and Virus
View moreAn Overview of Bioinformatics Methods for Analyzing Autism Spectrum Disorders
View moreAjmalicine and its Analogues against AChE and BuChE for the Management of Alzheimer's Disease: An In-silico study
View moreAdjunctive Immunotherapy of Mycobacterial Infections
View moreActivation of Melanocortin-4 Receptor by a Synthetic Agonist Inhibits Ethanolinduced Neuroinflammation in Rats
View moreAction of Anti-HIV Drugs and Resistance: Reverse Transcriptase Inhibitors and Protease Inhibitors
View moreA Spectrum of Topics for 2019: Advances in Neuroinflammation, Oxidative Stress, Obesity, Diabetes Mellitus, Cardiovascular Disease, Autism, Exosomes, and Central Nervous System Diseases
View moreA Review on the Phytochemistry, Ethnobotanical Uses and Pharmacology of Borago Species
View moreA Pooled Analysis of the Prognostic Significance of Brugada Syndrome with Atrial Fibrillation
View more